Skip to content

Clinical trials

Atrial Fibrillation trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Country / region: Hong Kong Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20053
20063
20072
20081
20091
20101
20111
20131
20142
20151
20172
20184
20193
20206
20211
20221
20234
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting8
Terminated4
Unknown status3
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation8
Chinese University of Hong Kong6
Sanofi6
Abbott Medical Devices5
Boehringer Ingelheim4
The University of Hong Kong4
Prince of Wales Hospital, Shatin, Hong Kong3
Bristol-Myers Squibb2
Astellas Pharma Inc1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation45
Stroke9
Cardiovascular Diseases4
Atrial Flutter3
Heart Diseases3
Embolism2
Thromboembolism2
Acute Coronary Syndrome1
Arrhythmias, Cardiac1
Atherosclerosis1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.